Academic Publications & White Papers

On 3 January 2014 the results of a year long investigation by the US Centers for Disease Control (CDC) into an outbreak of New Delhi metallo-β-lactamase (NDM)-producing carbapenem resistant Enterobacteriaceae (CRE) were released. Of[...]

In the current venture capital climate, it is easier to secure funding for late-stage, next-in-class therapeutic agents than for early-stage opportunities that have the potential to advance basic science and translational medicine. This funding paradigm[...]

The recent litigation in the District of Columbia Circuit attempting to suspend the public funding of human embryonic stem cell (hESC) research in the United States also threatens privately funded research. It has created an[...]

FDA is a troubled agency in need of fundamental reorganization. It has been criticized by Congressional watchdogs for years and recently, staff members sent a letter to Congress highlighting some of the problems they[...]